Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 3;32(5):814-828.e6.
doi: 10.1016/j.cmet.2020.09.006. Epub 2020 Sep 18.

Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo

Affiliations
Free article

Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo

Satotaka Omori et al. Cell Metab. .
Free article

Abstract

Cell senescence plays a key role in age-associated organ dysfunction, but the in vivo pathogenesis is largely unclear. Here, we generated a p16-CreERT2-tdTomato mouse model to analyze the in vivo characteristics of p16high cells at a single-cell level. We found tdTomato-positive p16high cells detectable in all organs, which were enriched with age. We also found that these cells failed to proliferate and had half-lives ranging from 2.6 to 4.2 months, depending on the tissue examined. Single-cell transcriptomics in the liver and kidneys revealed that p16high cells were present in various cell types, though most dominant in hepatic endothelium and in renal proximal and distal tubule epithelia, and that these cells exhibited heterogeneous senescence-associated phenotypes. Further, elimination of p16high cells ameliorated nonalcoholic steatohepatitis-related hepatic lipidosis and immune cell infiltration. Our new mouse model and single-cell analysis provide a powerful resource to enable the discovery of previously unidentified senescence functions in vivo.

Keywords: NASH; aging; p16Ink4a; senescence; single-cell transcriptomics.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests The authors declare that they have no conflicts of interest with respect to the contents of this article. RIKEN has filed patents of CUBIC reagents in which E.A.S. and H.R.U. are co-inventors. Part of this study was performed in collaboration with Olympus Corporation.

Publication types

Substances